🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to our NewFest Pride sponsor, Mount Sinai IAM! For Mount Sinai Health System's Center for Transgender Medicine and Surgery, visit mountsinai.org/locations/cent… Mount Sinai Department of Medicine

TY Endocrine Today for highlighting Endocrine Society opening plenary: “DM & Cardiometabolic Risk: From People to Populations” ✅ Creative Partnerships to meet people where they live, work, pray and play are 🔑 to ⬇️ cardiometabolic risk! The Ohio State University Wexner Medical Center healio.com/news/endocrino…

What a way to start the week. I’m here in Israel joining Roy Zucker and Shimrit Arbel at the start of their 3-day program training for about 25 primary care providers in gender affirming healthcare - a substantial effort to expand access for trans and gender diverse people here!

Our executive director ⁦Joshua Safer⁩ is in Israel joining in the training of primary care providers from across the country- expanding access to gender affirming healthcare for trans and gender diverse people!

A groundbreaking training course for family physicians on transgender care. Three full days with top professionals, providing exceptional exposure. Joshua Safer

A perfect activity for the end of #Pride month: joining Shimrit Arbel and Roy Zucker MD MSc with experience from Center for Transgender Medicine and Surgery - training primary care providers here in #Israel to expand care for transgender and gender diverse people here.

Our executive director Joshua Safer is ending #Pride month in #Israel with Roy Zucker MD MSc and Shimrit Arbel training primary care providers to expand health care for #trans and gender diverse people across the country.

Welcome to Mount Sinai Department of Urology Anne! So excited to have GURS matched Anne Yin from McGill University #reconstructiveurology Center for Transgender Medicine and Surgery

In transgender women, blood clot risk may not be connected to estrogen. It might be connected to health care access and other medical concerns. Read the Center for Transgender Medicine and Surgery Mount Sinai Health System Mount Sinai Department of Medicine Icahn School of Medicine at Mount Sinai report by endocrinologist Daniel Slack: authors.elsevier.com/a/1joe4,YplMsl…

Great work by our Center for Transgender Medicine and Surgery Mount Sinai Health System Mount Sinai Department of Medicine Icahn School of Medicine at Mount Sinai team led by Daniel Slack and Joshua Safer showing that blood clot risk in trans women may relate to care access and not to estrogen treatment. authors.elsevier.com/a/1joe4,YplMsl…

So excited to see our own Marci bowers from Center for Transgender Medicine and Surgery opening the 2024 WPATH scientific conference in Portugal. We have 17 Mount Sinai Health System Icahn School of Medicine at Mount Sinai presentations and are looking to learn much from the 1300+ other attendees!

Review by Rothman @DavidgePitts Joshua Safer and others The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels Discussed at #WPATH2024 endocrinepractice.org/article/S1530-… and my editorial endocrinepractice.org/article/S1530-…

In Press #EndocrinePractice by Joshua Safer Center for Transgender Medicine and Surgery et al Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis. Risks of thromboembolism much lower than previously thought #WPATH2024 endocrinepractice.org/article/S1530-…

Thank you #EndocrinePractice for featuring work by Center for Transgender Medicine and Surgery Icahn School of Medicine at Mount Sinai Mount Sinai Department of Medicine Mount Sinai Health System Dr. Daniel Slack with me showing less blood clot risk in transgender women. Also presenting at #WPATH2024!

Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgender women. Another reason CPA is not preferred say Center for Transgender Medicine and Surgery endocrinologists Daniel Slack and Joshua Safer. Read their comments: academic.oup.com/jcem/advance-a…

Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgender women. Read why my Center for Transgender Medicine and Surgery Mount Sinai Department of Medicine colleague Daniel Slack and I think this is another reason CPA is not preferred. academic.oup.com/jcem/advance-a…

November’s #EndocrinePractice by Joshua Safer and Dr Slack and others from Icahn School of Medicine at Mount Sinai Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis endocrinepractice.org/article/S1530-…

There is only one week left to apply for our two professional development programs, Future Leaders Advancing Research in Endocrinology (FLARE) (bit.ly/2N5iKxV) and Excellence in Clinical Endocrinology Leadership (ExCEL) (bit.ly/3waSFCh). #FLARE2025 #ExCEL2025

Great opportunity!!

This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals. Read more: endocrinepractice.org/article/S1530-… #endocrinology Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD